DrugCite
Search

HUMULIN U

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Humulin U Adverse Events Reported to the FDA Over Time

How are Humulin U adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Humulin U, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Humulin U is flagged as the suspect drug causing the adverse event.

Most Common Humulin U Adverse Events Reported to the FDA

What are the most common Humulin U adverse events reported to the FDA?

Blood Glucose Increased
42 (9.13%)
Blood Glucose Decreased
17 (3.7%)
Drug Ineffective
10 (2.17%)
Diabetes Mellitus Inadequate Contro...
7 (1.52%)
Feeling Abnormal
7 (1.52%)
Confusional State
5 (1.09%)
Hypoglycaemia
5 (1.09%)
Incorrect Dose Administered
5 (1.09%)
Medication Error
5 (1.09%)
Anxiety
4 (.87%)
Blood Glucose Fluctuation
4 (.87%)
Show More Show More
Chronic Obstructive Pulmonary Disea...
4 (.87%)
Condition Aggravated
4 (.87%)
Depressed Level Of Consciousness
4 (.87%)
Drug Exposure During Pregnancy
4 (.87%)
Injection Site Reaction
4 (.87%)
Ketoacidosis
4 (.87%)
Myocardial Infarction
4 (.87%)
Renal Failure
4 (.87%)
Therapeutic Response Decreased
4 (.87%)
Aphasia
3 (.65%)
Arthralgia
3 (.65%)
Blood Cholesterol Increased
3 (.65%)
Blood Pressure Increased
3 (.65%)
Burning Sensation
3 (.65%)
Cardiac Failure
3 (.65%)
Coronary Artery Occlusion
3 (.65%)
Dizziness
3 (.65%)
Drug Hypersensitivity
3 (.65%)
Eye Haemorrhage
3 (.65%)
Fall
3 (.65%)
Fatigue
3 (.65%)
Hypersensitivity
3 (.65%)
Hypokinesia
3 (.65%)
Injection Site Pain
3 (.65%)
Macular Degeneration
3 (.65%)
Memory Impairment
3 (.65%)
Osteoporosis
3 (.65%)
Pain
3 (.65%)
Renal Failure Chronic
3 (.65%)
Retinopathy
3 (.65%)
Staphylococcal Infection
3 (.65%)
Viral Infection
3 (.65%)
Weight Increased
3 (.65%)
Anaemia
2 (.43%)
Arthritis
2 (.43%)
Blindness
2 (.43%)
Blindness Unilateral
2 (.43%)
Blood Pressure Decreased
2 (.43%)
Chondropathy
2 (.43%)
Chronic Fatigue Syndrome
2 (.43%)
Cognitive Disorder
2 (.43%)
Depression
2 (.43%)
Diabetic Ketoacidosis
2 (.43%)
Diabetic Retinopathy
2 (.43%)
Disorientation
2 (.43%)
Dysstasia
2 (.43%)
Feeling Jittery
2 (.43%)
Fibromyalgia
2 (.43%)
General Physical Health Deteriorati...
2 (.43%)
Hospitalisation
2 (.43%)
Hypoglycaemia Unawareness
2 (.43%)
Hypoglycaemic Seizure
2 (.43%)
Hypoglycaemic Unconsciousness
2 (.43%)
Injection Site Erythema
2 (.43%)
Insomnia
2 (.43%)
Large Intestinal Haemorrhage
2 (.43%)
Leg Amputation
2 (.43%)
Localised Infection
2 (.43%)
Loss Of Consciousness
2 (.43%)
Muscle Spasms
2 (.43%)
Neoplasm Malignant
2 (.43%)
Neuralgia
2 (.43%)
Oedema Peripheral
2 (.43%)
Open Wound
2 (.43%)
Osteoarthritis
2 (.43%)
Pancreatitis
2 (.43%)
Pneumonia
2 (.43%)
Poor Quality Drug Administered
2 (.43%)
Premature Labour
2 (.43%)
Pruritus Generalised
2 (.43%)
Pyrexia
2 (.43%)
Rash Erythematous
2 (.43%)
Retinal Detachment
2 (.43%)
Road Traffic Accident
2 (.43%)
Sepsis
2 (.43%)
Shock Hypoglycaemic
2 (.43%)
Syncope
2 (.43%)
Urinary Tract Infection
2 (.43%)
Vision Blurred
2 (.43%)
Visual Acuity Reduced
2 (.43%)
Vomiting
2 (.43%)
Weight Decreased
2 (.43%)
Abdominal Distension
1 (.22%)
Abdominal Pain Upper
1 (.22%)
Abnormal Behaviour
1 (.22%)
Adverse Drug Reaction
1 (.22%)
Aggression
1 (.22%)
Allergy To Chemicals
1 (.22%)
Arthropathy
1 (.22%)
Atrioventricular Block Complete
1 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Humulin U, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Humulin U is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Humulin U

What are the most common Humulin U adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Humulin U, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Humulin U is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Humulin U According to Those Reporting Adverse Events

Why are people taking Humulin U, according to those reporting adverse events to the FDA?

Diabetes Mellitus
148
Diabetes Mellitus Insulin-dependent
18
Diabetes Mellitus Non-insulin-depen...
6
Type 1 Diabetes Mellitus
4
Gestational Diabetes
4
Type 2 Diabetes Mellitus
3
Show More Show More
Pancreatic Disorder
1
Blood Glucose Increased
1

Humulin U Case Reports

What Humulin U safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Humulin U. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Humulin U.